(0.07%) 5 473.28 points
(0.10%) 39 152 points
(0.37%) 17 783 points
(-0.22%) $80.65
(-3.66%) $2.66
(-0.78%) $2 312.70
(0.20%) $28.93
(3.50%) $1 020.90
(0.28%) $0.936
(0.70%) $10.68
(0.45%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics...
Stats | |
---|---|
今日成交量 | 244 755 |
平均成交量 | 755 112 |
市值 | 2.68B |
EPS | $-0.530 ( Q1 | 2024-05-07 ) |
下一个收益日期 | ( $-0.560 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-17.73 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0520 (0.15%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-31 | Rosen Terry J | Buy | 16 200 | Stock Option (right to buy) |
2024-05-31 | Kelley Susan L. | Buy | 16 200 | Stock Option (right to buy) |
2024-05-31 | Hampton Malcolm Garret | Buy | 16 200 | Stock Option (right to buy) |
2024-05-31 | Stein Jeffrey | Buy | 16 200 | Stock Option (right to buy) |
2024-05-31 | Morrison Scott W | Buy | 16 200 | Stock Option (right to buy) |
INSIDER POWER |
---|
21.44 |
Last 100 transactions |
Buy: 1 731 485 | Sell: 1 162 652 |
音量 相关性
IDEAYA Biosciences Inc 相关性
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
IDEAYA Biosciences Inc 相关性 - 货币/商品
IDEAYA Biosciences Inc 财务报表
Annual | 2023 |
营收: | $23.39M |
毛利润: | $19.38M (82.86 %) |
EPS: | $-1.960 |
FY | 2023 |
营收: | $23.39M |
毛利润: | $19.38M (82.86 %) |
EPS: | $-1.960 |
FY | 2022 |
营收: | $50.93M |
毛利润: | $48.83M (95.87 %) |
EPS: | $-1.320 |
FY | 2021 |
营收: | $27.94M |
毛利润: | $0.00 (0.00 %) |
EPS: | $-1.410 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
IDEAYA Biosciences Inc
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。